Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 161.00
+1.00 (0.63%)
At close: May 7, 2026
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 3.94 billion as of May 8, 2026. Its market cap has increased by 35.60% in one year.
Market Cap
3.94B
Enterprise Value
3.39B
Revenue
306.31M
Ranking
n/a
PE Ratio
38.59
Stock Price
161.00
Market Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 3.94B, an increase of 167.12%. That is a compound annual growth rate of 42.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.94B | 7.43% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| United Orthopedic | 9.61B |
| Hi-Clearance | 6.03B |
| Delta Asia International | 5.10B |
| WeLeader Biomedical | 3.13B |
| Medimaging Integrated Solution | 2.66B |
| A Plus Biotechnology | 2.51B |
| Applied BioCode | 2.31B |
| Wellell | 2.24B |